Estrogens and quality of life at the menopause

dc.contributor.author	Θεοδοσοπούλου, Ελένη	el
dc.contributor.author	Βλάχου, Ευγενία Δ.	el
dc.contributor.author	Κοτρώτσιου, Ευαγγελή Δ.	el
dc.contributor.author	Κιαγιάς	el
dc.contributor.author	Αναστασσίου	el
dc.date.accessioned	2015-04-28T15:07:16Z
dc.date.issued	2015-04-28
dc.identifier.uri	http://hdl.handle.net/11400/9174
dc.rights	Αναφορά Δημιουργού-Μη Εμπορική Χρήση-Όχι Παράγωγα Έργα 3.0 Ηνωμένες Πολιτείες	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/3.0/us/	*
dc.source	http://pharmakonpress.gr/	el
dc.subject	estrogens
dc.subject	Menopause
dc.subject	Oιστρογόνα
dc.subject	Εμμηνόπαυση
dc.title	Estrogens and quality of life at the menopause	en
heal.type	journalArticle
heal.classification	Medicine
heal.classification	Gynecology
heal.classification	Ιατρική
heal.classification	Γυναικολογία
heal.classificationURI	http://id.loc.gov/authorities/subjects/sh00006614
heal.classificationURI	http://id.loc.gov/authorities/subjects/sh85058092
heal.classificationURI	N/A-Ιατρική
heal.classificationURI	N/A-Γυναικολογία
heal.keywordURI	http://lod.nal.usda.gov/22969
heal.keywordURI	http://id.loc.gov/authorities/subjects/sh85083590
heal.identifier.secondary	ISSN: 10116583
heal.dateAvailable	10000-01-01
heal.language	en
heal.access	forever
heal.publicationDate	2001
heal.bibliographicCitation	Theodosopoulou, E., Vlachou, E., Kotrotsiou, E., Kiayias, J. and Anastassiou, C. (2001) Estrogens and quality of life at the menopause. "Review of Clinical Pharmacology and Pharmacokinetics, International Edition". [online] 15(3), pp.193-198. Available from: http://www.scopus.com [Accessed 28/04/2015].	en
heal.abstract	The term menopause refers to the final cessation of menstruation, either as a normal part of aging (loss of all follicles and ovarian function) or as the result of surgical removal of both ovaries. The average age at menopause in Western societies is 50-52 years. Menopause is associated with a loss of menstruation hormone levels, leading to potential problems of hot flashes, increased risk for osteoporosis, heart disease, Alzheimer's disease, dry vangina, night sweats, and decreased interest in sex. Hormone therapy improves emotions, decreased vasomotor symptoms, somatic symptoms, depression and reduces the risk of death and disability associated with osteoporosis and coronary heart disease. Quality of life is very important for women at the menopause and estrogen replacement therapy (ERT) offers substantial improvement in many aspects.	en
heal.publisher	Πλέσσα Ελένη Σ.	el
heal.publisher	Πλέσσας Σταύρος Τ.	el
heal.publisher	Πλέσσας Χαράλαμπος Τ.	el
heal.journalName	Review of Clinical Pharmacology and Pharmacokinetics, International Edition	el
heal.journalType	peer-reviewed
heal.fullTextAvailability	false